Deliver to Senegal
For best experience Get the App
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Trustpilot
Meera L.
3 weeks ago
Farhan Q.
2 months ago
Yusuf A.
1 month ago
Reema J.